October 28, 2020

The Niche

Knoepfler lab stem cell blog

Search Results for: Marcus Foundation

9 min read

There is a puzzle when it comes to the controversial idea of using cord blood for autism, because two of the strongest proponents are the autism cord blood program at Duke and for-profit, unproven stem cell clinics. On first glance it seemed like this was a bit of an odd couple to me. The links between the Duke autism program and one particular Panamanian stem cell clinic called generically enough “The Stem Cell Institute” appear to go beyond just their enthusiasm about cord blood …Read More

3 min read

Reading to them was one of my favorite things to do with my kids when they were little, but it’s a long way from Goodnight Moon to this week’s list of recommended reads, although “bee brain” may have got their attention. Please take a minute to complete our The Niche reader survey for a chance at a bundle of free stem cell swag including my 3 books and a t-shirt. Media James Gorman, NY Times, The Vikings Were More Complicated Than You Might Think …Read More

7 min read

A solid new, blinded placebo-controlled Phase II study from a Duke team clearly shows no benefit of cord blood for autism. Surprisingly, the team has said they are encouraged by the results. As a result, they apparently will continue this kind of work anyway despite their data. In contrast, I see the data as a probable stop sign. Few have been as upbeat over the years as this Duke team about the idea of cord blood for autism spectrum disorder. I have been one …Read More

3 min read

In 2014, I reported on a groundbreaking, but debated Duke stem cell-based clinical trial being launched for autism. Where does that trial stand today? (note that as of 2018-2020 I am very skeptical about stem cells for autism) The cord blood trial has continued. It is led by Dr. Joanne Kurtzberg, whom I interviewed about cord blood stem cells back in 2013 (see part 1 and part 2), where she provided some fascinating background. It is also notable that on the stem cell autism trial front, other efforts …Read More